IF ANY DISEASE owed its pathophysiological definition to one man, it is cystic fibrosis (CF) to Hans Ussing (Fig. 1) . The concepts and principles he put forward for coupling electrical current to movements of charged solutes preceded their application in studies of CF by nearly 30 years. Perhaps, ironically the single electrolyte disturbance first noted in CF sweat (13) was described at almost the same time that Ussing described his classic and now-famous treatment of active ion transport, entitled "Active transport of sodium as the source of electric current in the short-circuited isolated frog skin" (57) . No doubt, his most famous creation was the "Ussing chamber" (as it is now called) for measurements of spontaneous transepithelial voltage, short-circuit current, and conductance, but he was responsible for many, if not most, of the concepts underlying epithelial ion transport, among them: exchange diffusion, unidirectional fluxes and the flux-ratio equation, two-membrane hypothesis, and solvent drag, to mention a few, but to be fair this list is short and interested readers are directed to the splendid biographical essay by Hvid Larsen on Ussing's career accomplishments (33) .
But really, what is CF? Even now after more than 60 years, CF is still best known as a disease of thick, sticky mucus that clogs the lungs and kills children. Nonetheless, CF is basically a disease of epithelial electrolyte transport (44) . It affects the epithelia of hollow organs and glands: the sinuses, salivary glands, respiratory airways, liver bile ducts, pancreatic ducts, small intestine, colon, vas deferens, the cervicouterine tract, and, of course, sweat glands (Fig. 2) . Because of the number of different exocrine glands involved, it is sometimes referred to as an exocrinopathy (51) . All of these complications arise from the mutation in a single gene that encodes a protein best known for its ability to conduct chloride (21) , i.e., Cystic Fibrosis Transmembrane Regulator (CFTR, see Ref. 48) . Defects in this protein lead to Cl Ϫ impermeability in tissues where it is expressed (45) , but still, what links a defect in an electrolyte transport protein to the deadly mucus of CF?
It may be audaciously presumptive, but I would like to attempt an answer to this question by focusing on only three substances that are abnormal in CF: 1) mucus, 2) salt, and 3) HCO 3 Ϫ . Beginning with mucus, I simply ask the reader to consider the histopathology and appearance of mucoid substances found in affected organs.
Abnormal Mucus
Lungs. Most perilous are the changes that occur in the CF lung. Figure 3 compares a coronal section through a normal (left) with a section through a severely diseased CF (right) lung. The immediate question is "why?" Why does a lung that begins life normally (as the lung on the left) with time become so devastated, destroyed, or, as we more politely say, "remodeled," as is the lung on the right? Clearly, most of the airways of the affected lung are filled with purulent pus, and what was described early on as concretions of mucus or mucoid sub-stance that filled the small airways, where lung disease was presumed to begin, even before purulent secretions appear ( Fig. 3) (8, 60) . These lungs are characterized by bronchiectatic lesions that fill with purulent mucus that block air passage until so much of the lung is involved that respiration becomes impossible.
Intestine. As another example (Fig. 4) , we can see mucus partially covering the surface of a resected specimen of the small intestine from a CF patient. The image may not appear so remarkable, yet the pathologist who examined the specimen commented that he could not remove the mucus coat without removing the underlying epithelial cells. This comment is consistent with the general notion that CF mucus is not only thick and viscid but also adhesive.
Glands. Unfortunately, opportunities to assess the properties of mucus in CF (as shown in Fig. 4 ) are few, and most conclusions are based on the histologic and microanatomic appearance of tissues such as in Brunner's glands (Fig. 4) , where duct blockage appears to result in continued accumulation of mucoid material that distends the duct and acinar lumens, ultimately forming lacunae lined by transformed squamous epithelial cells. In general, the material appears mucoid and stains with periodic acid Schiff (PAS) reagent (12, 15) . Because other tissues (e.g., pancreas, bile ducts, gall bladder, submucosal glands, salivary glands, and uterine cervix) can all show very similar abnormalities that arise from mucus, "cystic fibrosis of the pancreas" is truly "mucoviscidosis" (a general state of thick mucus) of many organs. Thus it seems this disease was misnamed. The fact that advances in understanding CF over the past three decades have occurred mainly in understanding fluid and electrolyte transport probably contributed to the puzzling fact that the name "mucoviscidosis," introduced by Farber 65 years ago (16) , has been all but forsaken. Like Farber, I see "cystic fibrosis" more clearly as "mucoviscidosis."
Abnormal Salt
Airways. The first application of Ussing's chamber to CF tissue appeared in 1983 when Knowles et al. (29) showed that excised nasal tissues from CF subjects spontaneously displayed significantly more lumen-negative transepithelial potential differences (TEP) and lower transepithelial conductances (G t ) than did tissues from control subjects ( Table 1) . The results corroborated their groundbreaking observations of luminal TEPs in vivo in airways (28) and in the sweat duct (43) . Even though these studies of native tissue in vitro (29) did not reveal significantly increased short-circuit current or net flux of Na ϩ or Cl Ϫ , the larger effect of the Na ϩ channel inhibitor amiloride on the spontaneous TEP in CF tissue supported the interpretation that active Na ϩ absorption was enhanced in CF airways (28) , which in turn supported the idea that CF mucus was thick and viscid due to dehydration caused by excessive absorption of salt and water. The advent of confocal microscopy made measurements of specimen thickness possible and provided further support for this concept in air-liquid interface cultures of primary airway epithelial cells. Cultures from CF subjects developed and maintained an airway surface fluid depth that was only about one-third normal and had significantly enhanced rates of fluid removal (active absorption) from the surface layer (Fig. 5) (34) . While this evidence supports the now commonly accepted idea that "mucoviscidosis" is caused by excessive absorption of Na ϩ (and therefore fluids) (7), it is important to recognize that these studies were carried out on cell cultures not native tissues, although the cultured cells were clearly well differentiated. However, two observations, one in sweat glands and the second in other organs affected in CF, leave me less certain of this cause of "mucoviscidosis."
Sweat glands. The sweat glands in CF reflect two fundamental failures in electrolyte transport in this disease: to secrete fluids (50) and to absorb salt (43) . Intuitively, the failure to secrete fluids might compound the problem of dehydrated mucus just as would an enhanced absorption of Na ϩ . However, the failure to absorb electrolytes places this defect diametrically opposed to the enhanced salt absorption in the lung. Figure 6 illustrates the functions of a normal and a CF sweat gland, but I should note that thermoregulatory (cholinergically mediated) secretion of sweat is not affected, whereas ␤-adrenergically mediated secretion (here and in other organs) is defective in CF. Thus, during sweating in CF or unaffected individuals, normal volumes of fluid are secreted into the water-impermeable sweat duct where normally NaCl is absorbed in great excess relative to water, thus producing a hypotonic sweat on the skin that contains ϳ20 mM NaCl (Fig.  6, top) . However, in CF, the sweat duct fails to efficiently absorb salt and thus sweat emerges that contains four to five times more NaCl or ϳ100 mM (Fig. 6, bottom) . Note that in this tissue, as in the airway, the lumen is much more electronegative relative to the interstitium in the CF duct than in the normal duct; i.e., Ϫ77 mV vs. Ϫ7 mV (46) even though the rate of salt absorption is depressed by three-to fourfold compared with normal absorption (Fig. 4) (6) . Also, like the airway, despite the fact that salt absorption is clearly much less in the CF sweat duct, the effect of amiloride on its spontaneous TEP is much larger than on that of the normal duct, depolarizing the normal duct by only ϳ10 mV and the CF duct by ϳ100 mV (5) . It must be noted that neither the magnitude of the TEP nor the impact of amiloride on the TEP can be taken as a measure of the underlying net salt transport activity.
This discrepancy in salt absorption between the airways and sweat ducts requires that we look to other affected organs and begs for an explanation since absorption in both tissues requires the same anion channel for the uptake of Cl Ϫ and the same cation channel for the uptake of Na ϩ . The cation channel is Epithelial Na Channel (ENaC) known for its sensitivity to amiloride, and the anion channel is Cystic Fibrosis Transmembrane Regulator (CFTR), cloned in 1989 as the defective gene in CF (26, 48, 49) . Numerous functions have been attributed to the CFTR protein (32) , but the best known, most commonly accepted, and the one that pertains here is that of a Cl Ϫ -selective anion channel that together with ENaC mediates the concurrent absorption of Na ϩ and Cl Ϫ across the apical membrane of some absorptive epithelia. Thus salt absorption is mediated by ENaC and CFTR in the ducts of sweat, salivary, and bronchial submucosal glands, as well as in the colon, uterine cervix, and airways but not in the small intestine, pancreas, liver, or gall bladder. All of these organs are affected in CF, and all, except the sweat glands (which secretes almost no mucus), are compromised by mucus adherence and blockage. These results are tabulated in Table 2 , which dramatizes the conundrum of how a defect in CFTR can cause the same pathological mucoviscidosis by altering a mechanism that is not common to all the affected tissues.
The following conclusions are based on what I have reviewed: 1) The same defective anion channel (CFTR) paradoxically results in enhanced salt absorption in CF airways and inhibited salt absorption in CF sweat ducts. 2) Not all tissues affected by mucoviscidosis express ENaC-CFTR-dependent salt/fluid absorption. 3) Enhanced fluid absorption does not appear to explain mucoviscidosis in all affected organs.
Abnormal HCO 3

Ϫ
Since it seems unlikely that the thick mucus in CF is due to aberrant mucus biosynthesis, and since hyperabsorption does not seem to explain mucoviscidosis in all the affected mucusproducing organs, I would like to consider whether there is a common denominator. Looking back, the name "cystic fibrosis of the pancreas" (the organ first associated with the disease) suggests a starting point (4) . Of all the organs of the body, the pancreas is the organ of HCO 3 Ϫ secretion, which almost immediately implicates it in the disease process, but this anion has been neglected in favor of studies of Cl Ϫ , Na ϩ , and fluid, possibly because physiologists do not like HCO 3 Ϫ and for good reason: HCO 3 Ϫ is a salt, a gas, a base, and a chelator; it is a pain to study and thus frequently is omitted or ignored even though it is the most important extracellular buffer.
After elevated NaCl was found in the sweat (14) , HCO 3 Ϫ was the next ion found to be abnormal in CF. Hadorn et al. (22), Gaskin et al. (19) , and Kopelman et al. (30) all found that even in CF patients with sufficient pancreatic enzymes to support digestion, the concentration and secreted amounts of HCO 3 Ϫ were significantly depressed in pancreatic juices collected in vivo compared with control subjects. The defect in HCO 3 Ϫ secretion extends beyond the pancreas and is present in other tissues as well. In the duodenum, Pratha et al. (40) found that cAMP-mediated HCO 3 Ϫ secretion was almost fivefold greater in normal than in CF tissue. Since access to human tissue is limited, the creation of the CF mouse model lacking the expression of CFTR protein has been extremely instructive for gastrointestinal abnormalities; similar results were observed in the duodenum (9), jejunum, and ileum (52) as well as in the colon (23) and gall bladder (11) . I should note that cAMP-mediated HCO 3 Ϫ secretion (i.e., CFTR dependent) is not the only source of HCO 3 Ϫ in the gut (40, 53) . In the airways, Smith and Welsh (54) found a cAMPmediated HCO 3 Ϫ -dependent short-circuit current (I sc ) in primary cultures of human bronchial epithelial (HBE) that was not present in CF-HBE cells, and Coakley et al. (10) observed that compared with HBEs from normals, CF-HBEs were significantly slower to correct for an acid load in the airway surface liquid, apparently secondary to an inability of CF cells to secrete HCO 3 Ϫ normally. Song et al. (55) measured the pH of secretions from tracheobronchial submucosal glands and found the pH of CF secretions to be 0.6 pH units lower than normal secretions, which would translate into more than a threefold difference in HCO 3 Ϫ concentration, assuming a physiological level of CO 2 at 5%.
Even in the sweat gland, the pH of CF sweat tends to be more acid, but intriguingly, whereas sweat ducts from patients with severe CFTR mutations (such as ⌬F508) show little if any HCO 3 Ϫ conductance, patients with the "milder" mutation R117H retain substantial HCO 3 Ϫ conductance (47) and generally do not have pancreatic insufficiency. In the male reproductive tract, the seminal fluid is normally highly alkaline (pH 8.2; calculated HCO 3 Ϫ ϳ150 mM), whereas in CF, this fluid is acidic (pH ϳ6.6; calculated HCO 3 Ϫ Ͻ5 mM) (17, 25) . A review of the literature shows that there is either direct evidence or good, indirect evidence that all of the glands that are affected in CF also secrete HCO 3 Ϫ (Table 2 ). There is a close correspondence between the ability to secrete HCO 3 Ϫ in all organs pathologically affected in CF and, the ability to secrete gel-forming mucins, excepting the sweat gland, which secretes almost no mucus and is not structurally affected.
The single point I make here is that CFTR-dependent HCO 3 Ϫ secretion is defective in CF epithelia.
Is There Evidence That HCO 3 Ϫ is Linked to Mucoviscidosis?
The evidence I have reviewed above leads to a new hypothesis that HCO 3 Ϫ is required for the normal discharge of gelforming mucins. To validate that hypothesis, we designed experiments to test the impact of manipulating conditions affecting HCO 3 Ϫ secretion on mucus discharge. We fabricated a simple temperature-controlled apparatus from syringe barrels, rubber stoppers, O-rings, and glass capillaries (18) and vertically mounted mouse ileums (5-6 cm) for bottom-to-top perfusion (ϳ1 ml/min) of the lumen with defined solutions. The latter shows an enormous number of ectatic lesions (arrows) with most airways completely filled and obstructed with purulent mucoid accumulations (black arrows). Examined microscopically, the lumens of normal small airways are virtually free of secretions (bottom left); in contrast, bronchioles from a CF patient can be obstructed and distended by mucus secretions even without significant evidence of inflammation (bottom right). The destruction demands "Why?" a defect in electrolyte transport is so destructive. The coronal sections are courtesies of Walter Finkbeiner, University of California, San Francisco, and the CF cross section is a courtesy of Carl Doershuk (Case-Western Reserve University).
The luminal perfusate was collected in aliquots at intervals of 3-5 min during the experiment. The solutions bathing the serosal surface (external) were also defined and changed as needed. The collected perfusates were assayed for mucus content by WGA-lectin binding or by PAS staining of the filtrand retained on imobilon-P film (an adaptation of the dot blot technique) (2, 18, 35) .
We monitored mucus discharged into the lumen before and after stimulation [by PGE 2 or serotonin (5-HT)] in the presence and absence of various inhibitors. We found that, independent of the method of stimulation or the assay technique, when HCO 3 Ϫ was absent from the serosal compartment bathing the tissue, the amount of mucus appearing in the perfusate was significantly depressed (Fig. 7) . Adding DIDS to the bath in the presence of HCO 3 Ϫ [to block the Na ϩ bicarbonate cotransporter (NBC)], also markedly reduced the amount of mucus discharged into the luminal perfusate (Fig. 7) . These results show rather convincingly that the presence of HCO 3 Ϫ , and presumably its concurrent secretion, are needed for normal mucus discharge, but to be relevant to the disease, the effect should also depend on CFTR function.
When we used ileums from mice homozygous for the severe ⌬F508 mutation, which disrupts processing of the CFTR protein to the membrane, we observed that the amount of mucus released did not discernibly increase with stimulation and was not affected by the presence or absence of HCO 3 Ϫ (Fig. 8) . We also found that applying naphthalen-2-ylamino-acetic acid (3,5-dibromo-2,4,-dihydroxy-benzylidene)-hydrazide (GlyH-101; courtesy A. Verkman) to block CFTR substantially reduced mucus discharge (not shown). These results strongly implicate CFTR as being critical to mucus discharge, presumably via a role in supporting HCO 3 Ϫ secretion.
Are Other Organs Affected Similarly?
I have already emphasized that CF is a multiorgan disease of mucus pathology. Thus, if the lack of HCO 3 Ϫ is a unifying defect, one would predict that the effects of HCO 3 Ϫ should be present in other tissues in addition to the ileum. We thus tested the mouse reproductive tract since the cervical mucus of CF women is more viscous and undergoes little if any cyclical thinning (31) . We adapted the perfusion system described above to the mouse uterus (a smaller tissue) by cannulating the vaginal os and one of the uterine horns while ligating the other so that the organ could be mounted and vertically perfused akin to the preparation of the ileum (35) . We first observed that stimulating mucus discharge reproducibly from this organ required both carbachol (a muscarinic cholinergic agonist) and PGE 2 simultaneously and further that in terms of mucus discharged, this tissue seemed to be more sensitive than the ileum to disturbing HCO 3 Ϫ transport. In bath solutions replete with HCO 3 Ϫ , we found a five-to sixfold increase in the amount of mucus in the perfusate within the first 5 min after stimulation (Fig. 8) ; however, if HCO 3 Ϫ was removed from the bath, or DIDS or GlyH-101 was added, or if the reproductive tract was from a CF mouse, virtually no mucus was discharged into the perfusate (Fig. 8) (35) . Of note, the two organs predominantly secrete different mucins: the ileum secretes MUC2 (3) and the uterus secretes MUC5B (20) . Thus the effect of HCO 3 Ϫ on mucus discharge is not mucin or tissue specific, and HCO 3 Ϫ participates in the formation of mucus gels in this tissue as well.
But is The Effect on Mucus Discharge Just Because of Decreased Fluid Secretion?
I must address the fact that CFTR is central to cAMPmediated fluid (Cl Ϫ ) secretion (50) and that concurrent fluid secretion with mucus secretion may be requisite to transport mucus by a lavage effect from the tissue into the perfusate. If fluid secretion in the gut or uterus is dependent on HCO 3 Ϫ , the depressed discharge of mucus into the luminal perfusate could be due to decreased fluid secretion and not directly to the lack of HCO 3 Ϫ per se. Indeed, if we inhibited the driver for fluid secretion, the Na ϩ /K ϩ /2Cl Ϫ cotransporter (NKCC) with bumetanide, stimulated mucus discharge was strongly depressed in both the intestine and the uterus (Fig. 9) . These results demonstrated that the transport of gel-forming mucins from the crypts, intervillar space, and uterine glands depends on concurrent fluid secretion and demands an evaluation of the effect of removing HCO 3 Ϫ on fluid secretory activity. We measured fluid secretion gravimetrically in closed loops of ileums (18), but since the uterus is much smaller, we devised a volumetric measure of fluid secretion by ligating the vaginal os and one uterine horn while then cannulating the other horn with a small glass capillary (280 M i.d. ϫ 3 cm) (35) . After equilibration, increases in weight of the loops and advances of the fluid-air interface meniscus in the connected capillary were converted to rates of fluid secretion. In both preparations, removing HCO 3 Ϫ , inhibiting transport by adding DIDS or GlyH-101, or using CF mouse tissues did not affect stimulated fluid secretion compared with controls in HCO 3 Ϫ -replete medium; only addition to the bath of the secretory inhibitor bumetanide blocked fluid secretion (Fig. 9) . These results show that the fluid stimulated concurrently with mucus discharge was not affected by the presence or absence of HCO 3 Ϫ and that this fluid secretion almost certainly does not depend on CFTR. Thus 1) mucus discharge requires HCO 3 Ϫ , CFTR, and fluid secretion; 2) fluid Inset: an isolated sweat gland as a single coiled tubule with the secretory coil in the left half of the image connected to, but distinguishable from, the reabsorptive duct in the right half of the image, which is illustrated at the bottom. Thermoregulated sweating is normal in CF and secretes the same load of isotonic precursor sweat from the secretory coil (blue and red cells on the left) to the more distal reabsorptive ducts (pale blue cells on the right).
As the secreted fluid passes through the normal duct (top), Na ϩ and Cl Ϫ are absorbed in excess of water, yielding a quite hypotonic sweat secretion on the skin surface. In contrast, as the fluid passes through the CF sweat gland, Cl Ϫ and consequently Na ϩ cannot be efficiently absorbed, yielding a much higher concentration of excreted salt in the sweat (bottom). Note that even though the rate of salt absorption in the normal duct is fivefold greater than in the CF duct, the transepithelial voltage associated with normal absorption is only about 1/10 of that of the CF duct. Thus the transepithelial potential (Vt) indicates relative separation of charge due to the absorptive process and not the rate of the Na ϩ absorption. Here the issue becomes a bit "explosive" if we recall that intracellularly mucins are stored highly condensed and compacted in granules (58) (Fig. 10) . Furthermore, the gel-forming mucins are massive glycoprotein molecules that can be millions of Daltons in weight and microns in length (27) . The core protein is a long polymer highly populated with polysaccharide side chains that carry an extremely large number of fixed negative charges. The electrostatic forces from the negative charges are critical to keeping the deployed mucin molecule extended, making it almost "frictionless" and creating its gel-forming ability (39, 56) . Upon quick reflection, it is easy to see that the cell encounters a huge problem in overcoming the repulsive electrostatic forces of the anionic charges as it packs these enormous molecules in intracellular granules for storage until secretion. Its solution is simple: the forces of the negative charges are neutralized and shielded behind the positive charges on small cations, namely, Ca 2ϩ and protons, i.e., a pH Ͻ 6 and Ca 2ϩ concentrations possibly Ͼ200 mM (37, 38, 58) . Protons associate with individual anionic sites to neutralize charge, and Ca 2ϩ not only neutralizes charge but also forms divalent electrostatic bridges between anionic sites that stabilize the molecule. Upon secretion of the granule, the mucins virtually explode and expand within a couple of seconds to a volume that is up to three orders of magnitude larger than the condensed mucins. Rapid expansion of the gel is likely important for forming the gel from these reptating molecular strings, but the shielding cations must be removed before this phenomenon can occur. The negative charges on the fixed anionic sites must be exposed so that their repulsive electrostatic forces can "explode" the condensed mucin molecule into the massive expansion that will form the mucin gel as dramatized in Fig.  10 .
The displacement of Ca 2ϩ is presumed to be due to simple cation exchange of Ca 2ϩ and H ϩ for monovalent Na ϩ and K ϩ in the mucin matrix upon exocytotic release of the mucin granule and that the mucin would then swell by a Donnan effect as these ions contribute to the osmotic pressure in the mucin matrix (1) . However, the efficiency of this exchange should depend on the relative attraction of the cations for the fixed anionic sites of the mucin. If Ca 2ϩ is more strongly attracted to the mucin sites, for example, than Na ϩ , the process should be slower and may not go to completion. However, if the competition is between anions for Ca 2ϩ , and the competing anion is mobile and binds Ca 2ϩ more strongly than the fixed anions, the displacement of Ca 2ϩ within the mucin molecule is virtually assured and the cation exchange is all but guaranteed. Now, enter HCO 3 Ϫ as the competing mobile anion. HCO 3 Ϫ exists in equilibrium with its salt CO 3 Ϫ2 , which can form CaCO 3 , while HCO 3 Ϫ itself can also form CaHCO 3 ϩ to tie up Ca 2ϩ (36) . By illustrative analogy to coiffures, Fig. 10 illustrates the predicted effect of HCO 3 Ϫ on condensed mucins as they are excreted. More specifically, as illustrated less poetically in Fig.  11A 
Can We Cause Mucoviscidosis?
Based on these observations and notions, one might predict that removing HCO 3 Ϫ would reduce the amount of mucus released from the epithelia, as we demonstrated above (Figs. 7 and 8) and "cause cystic fibrosis" in the subject tissue. In fact, when we looked for mucus in mouse uterine glands with either PAS or MUC5B antibody, we observed that mucus appeared to be accumulated, if not "stuck," within the ducts of the glands incubated without HCO 3 Ϫ compared with those incubated with HCO 3 Ϫ (Fig. 12) . I describe the results as "mucoviscidosis." These findings and conjectures tempt me to remark on what may happen in CF and why mucus appears to be excreted excessively, even if less mucins are produced (24) . I surmise that inflammatory responses must appear, but first, I should note that the loss of organ function in CF is generally a gradual process. The lungs, pancreas, and liver are usually destroyed over years, if not decades, apparently one or a few subunits, acini, or lobules at a time. Thus mucus obstruction is not sudden and universal even in the same organ; some threshold or trigger must be crossed or activated to initiate the pathogenic event. The gradual process also informs that, in relative terms, the localized pathogenic event is infrequent. Hence, I can imagine that when mucus stagnates, if not cleared quickly, it may start a viscous cycle that leads to the demise of the affected unit. That is, if stagnated mucus is not removed (e.g., by lavage), the tissue must recognize it as debris requiring removal by innate inflammatory processes, which would including more mucin secretion. Without HCO 3 Ϫ to support mucus discharge, the added mucins will aggregate and accumulate along with previously accumulated debris, which they are intended to, but cannot, remove. Hence, mucus accumulates until eventually the tissue is damaged, remodeled, and destroyed by normal inflammatory responses. These events impede the clearance of pathogens in the lungs and of prematurely activated proteolytic enzymes in the pancreas, rendering these organs particularly vulnerable. I do not intend to ignore the role of fluid secretion in this process. Indeed, the data presented here show that it is crucial, and it remains prudent to appreciate that the pathology in CF is likely multifactorial, involving Na ϩ absorption, Cl Ϫ secretion, HCO 3 Ϫ secretion, and other confounding phenomena.
Before ending what may be viewed as an enormous amount of speculation, I would be remiss were I not to offer at least two caveats. First, as Einstein warned, "make it simple, just not too simple." It is entirely possible, and very likely in fact, that I have oversimplified the role HCO 3 Ϫ in unraveling mucins. For example, mucins are likely packaged in very structured arrays maintained not only by cationic bridges and shielding but also by intramolecular disulfide and hydrophobic bonds. Thus unraveling the nascent mucin must involve efficient cleavage and breaking of these bonds as well. Moreover, there may be a substantial, perhaps greater, impact of HCO 3 Ϫ on this process, especially if higher pH is requisite or if Ca 2ϩ must be removed from binding sites in nodes that organize the protein cores into loops of mucin molecules (27, 42) .
Second, I have presumed that HCO 3 Ϫ existing in the luminal medium facilitates the mucin expansion but perhaps HCO 3 Ϫ is concurrently secreted with mucin. Based on my training, I assume that HCO 3 Ϫ is secreted primarily, if not exclusively, by the neighboring transport epithelial cells that surround mucinsecreting goblet cells and are the source of the luminal HCO 3 Ϫ . Intuitively, based on characteristics of electrolyte-transporting cells that seem to be missing in goblet cells, I expect that goblet cells cannot participate in significant HCO 3 Ϫ secretion. However, the evidence that Bestrophin-2 is a HCO 3 Ϫ -permeable channel (41) in the basolateral membrane of goblet cells (59) raises this question to an intriguingly new level.
Understanding of the process and, in particular, how and where HCO 3 Ϫ influences this new-found role, requires much more intense and intricate investigation, but perhaps what we have seen here will provide a new view of CF animated by bringing the disease process to basic principles of chemistry and physics. In closing, I leave you with three final points:
1)CFTR-dependent HCO 3
Ϫ secretion is defective in CF. 2) HCO 3 Ϫ is required for normal mucus formation. 3) Defective HCO 3 Ϫ transport leads to "mucoviscidosis."
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